ESPAC-4 trial: A summary
Singh, R.Kumar.
National Medical Journal of India 30(4): 208-209
2017
ISSN/ISBN: 0970-258X PMID: 29162754 Document Number: 692695
Document emailed within 1 workday
Related Documents
Francis, T.; Korns, R.F. 1955: Evaluation of 1954 field trial of poliomyelitis vaccine: synopsis of summary report American Journal of the Medical Sciences 229(6): 603-612Freeman, S.A.; Moon, S.D.; Spencer, J.M. 2012: Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial Journal of Drugs in Dermatology: Jdd 11(12): 1410-1414
Landgraf, J.M.; Nelson, E.C. 1992: Summary of the WONCA/COOP International Health Assessment Field Trial. The Dartmouth COOP Primary Care Network Australian Family Physician 21(3): 255-7 260-2 266-9
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Kamiizumi, K.; Yamane, M. 1984: Utilization of nursing summary at patient discharge: with special reference to a summary on patients with myocardial infarction Kangogaku Zasshi 48(6): 663-669
Ware, J.E.; Kosinski, M.; Bayliss, M.S.; McHorney, C.A.; Rogers, W.H.; Raczek, A. 1995: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study Medical Care 33(4 Suppl): AS264-AS279
Federman, A.D.; Sanchez-Munoz, A.; Jandorf, L.; Salmon, C.; Wolf, M.S.; Kannry, J. 2017: Patient and clinician perspectives on the outpatient after-visit summary: a qualitative study to inform improvements in visit summary design Journal of the American Medical Informatics Association: Jamia 24(E1): E61-E68
Mary Duryee 1992: Mandatory Court Mediation: Demographic Summary and Consumer Evaluation of one Court Service : Executive Summary Family Court Review 30(2): 260-267
Mary Duryee 1992: Mandatory Court Mediation: Demographic Summary and Consumer Evaluation of one Court Service : Executive Summary Family Court Review 30(2): 260-267
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Gotto, A.M. 1997: The Multiple Risk Factor Intervention Trial (MRFIT). a return to a landmark trial JAMA 277(7): 595-597
Mahé, E.; Sachwald, J.; Brunet, M.; Clavel, B.; Debaud, B.; Meeus, L. 1978: Immune therapy trial with Corynebacterium in patients with E.N.T. cancer. (Code name of the trial: "Reticulo-stimuline") Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 95(9): 629-635
1990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Nilsson, P. 2003: Conclusions in an Australian trial differ from those in the ALLHAT trial: ACE inhibitors are more effective than thiazides in elderly men with hypertension Lakartidningen 100(13): 1118-1120
Ndebele, P.M.; Wassenaar, D.; Munalula, E.; Masiye, F. 2012: Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi Bmc Medical Ethics 13: 29
Evans, S.; Pocock, S. 2001: Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial Bmj 322(7286): 569-570
Bakari, M.; Munseri, P.; Francis, J.; Aris, E.; Moshiro, C.; Siyame, D.; Janabi, M.; Ngatoluwa, M.; Aboud, S.; Lyamuya, E.; Sandström, E.; Mhalu, F. 2013: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/Ii HIVIS 03 trial Bmc Public Health 13: 1149
Suzuki, S. 1979: Status of the pre-trial psychiatric tests represented in the Akabori trial Seishin Shinkeigaku Zasshi 81(4): 259-273
Altman, D.; Carroli, G.; Duley, L.; Farrell, B.; Moodley, J.; Neilson, J.; Smith, D. 2002: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial Lancet 359(9321): 1877-1890